Advantages and limitations of propensity score methods to analyze non-randomized clinical trials

被引：1
|
作者：
Gayat, E. [1 ,2 ]
Porcher, R. [1 ,2 ,3 ]
机构：
[1] INSERM, U717, F-75010 Paris, France
[2] Univ Paris Diderot, Sorbonne Paris Cite, Epidemiol Clin & Biostat, UMR S717, F-75010 Paris, France
[3] Hop St Louis, Dept Biostat & Informat Med, F-75010 Paris, France
来源：
REANIMATION | 2012年 / 21卷 / 01期
关键词：
Propensity score; Propensity; Matching; Methodology; Intensive Care;
D O I：
10.1007/s13546-011-0422-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The propensity score (PS), defined as a patient's probability of receiving a specific treatment conditional on the observed covariates, is a method that leads to control the bias associated with the non-randomly assigned treatment allocation in observational studies. PS methods have been increasingly used in the last 10 years. The quality of reporting PS in the intensive care medicine literature should be improved. This review aims to present the theory of PS, illustrated with an example and provides recommendations to the investigators in order to improve the reporting of PS analyses.
引用
收藏
页码：109 / 116
页数：8
相关论文
共 50 条
  • [41] Using non-randomized trials to assess the clinical benefit of systemic anti-cancer treatments: Viable or not?
    Xander, N. S. H.
    Leeneman, B.
    Dingemans, A. -M. C.
    Fiets, W. E.
    de Jong, W. K.
    Uyl, N. E. M.
    Wymenga, A. N. M.
    Reyners, A. K. L.
    Uyl-de Groot, C. A.
    EUROPEAN JOURNAL OF CANCER, 2024, 209
  • [42] THE USE OF NON-RANDOMIZED DATA IN CLINICAL HYPERTHERMIA RESEARCH
    LUK, KH
    FRANCIS, ME
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1984, 10 (06): : 944 - 945
  • [43] On the continuing relevance of prospective non-randomized clinical data ...
    Saksena, S
    JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY, 1998, 2 (03) : 233 - 234
  • [44] On the Continuing Relevance of Prospective Non-Randomized Clinical Data . . .
    Sanjeev Saksena
    Journal of Interventional Cardiac Electrophysiology, 1998, 2 : 233 - 234
  • [45] An empirical comparison of the harmful effects for randomized controlled trials and non-randomized studies of interventions
    Dai, Minhan
    Furuya-Kanamori, Luis
    Syed, Asma
    Lin, Lifeng
    Wang, Qiang
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [46] ADVANTAGES AND DRAWBACKS OF THE ZELEN DESIGN FOR RANDOMIZED CLINICAL-TRIALS
    HORWITZ, RI
    FEINSTEIN, AR
    JOURNAL OF CLINICAL PHARMACOLOGY, 1980, 20 (07): : 425 - 427
  • [47] Section original article: Advantages and limitations of Twin Assessment of Clinical Trials (TACT)
    Porzsolt F.
    Costa I.C.B.D.O.
    Thomaz T.G.
    Journal of Public Health, 2009, 17 (6) : 425 - 432
  • [48] Open-label non-randomized versus double-blind randomized antidepressive treatment: What are the advantages of clinical decision over randomization?
    Deuschle, M
    Krumm, B
    Bindeballe, N
    Colla, M
    Hamann, B
    Lederbogen, F
    Gilles, M
    Heuser, I
    PHARMACOPSYCHIATRY, 2004, 37 (06) : 299 - 302
  • [49] Propensity score weighted multi-source exchangeability models for incorporating external control data in randomized clinical trials
    Wei, Wei
    Zhang, Yunxuan
    Roychoudhury, Satrajit
    STATISTICS IN MEDICINE, 2024, 43 (20) : 3815 - 3829
  • [50] Effects of blood flow restriction exercise on hemostasis: a systematic review of randomized and non-randomized trials
    Nascimento, Dahan da Cunha
    Petriz, Bernardo
    Oliveira, Samuel da Cunha
    Leite Vieira, Denis Cesar
    Funghetto, Silvana Schwerz
    Silva, Alessandro Oliveira
    Prestes, Jonato
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2019, 12 : 91 - 100
12345